Member Info for Rockefellow

Https://investors.puretechhealth.com/events/event-details/puretech-present-2025-half-year-results

Joint house broker has a 508p target.I wonder what UBS will be.

New dynamic CEO,new chairman.UBS.Blockbuster LYT100.Cobenfy.Gallop.Seaport.Plenty to be excited about £30 here we come.

I assume will initiate post interims

If Deupirfenidone becomes Standard of Care for IPF ..would be worth $10bn plus.over $40 per share.

Still plans coverage apparently .

He can bring in new late stage projects and build up portfolio.A good move.

At 10p with 347m shares is £34.7m.

Https://ldnbtc.com/wp-content/uploads/Vinanz-Limited-Financial-Statements-18-months-ended-February-2025.pdf

Not sure how many option left.

If AZN is considering ..it must be on Puretechs wishlist.

UBS do intend to cover apparently .

I have sent several messages to IR re UBS.No reply at all.Pathetic.

Interesting

Insmeds market cap went up $3bn on phase 2b date for lung disease.not IPF.. but this would happen to Pure if they had US analysts covering

Still 3.2m.AGM 16/6

Https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-global-healthcare-conference-0/

Https://puretechhealth.com/images/PRTCCorpPresentation.pdf

Will be peanuts to these guys.they can take the hit.one day they will close

Https://news.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-global-healthcare-conference-0